SAMHSA has announced two grant programs totaling that will expand access to MAT for OUD and prevent the misuse of prescription drugs. By reducing barriers to accessing the most effective, evidenced-based treatments, this funding reflects the priorities of HHS’ Overdose Prevention Strategy, as well as its new initiative to strengthen the nation’s mental health and crisis care systems. The two grant programs are:
1. SPF Rx: provides funds for state agencies, territories, and tribal entities that have completed a SPF State Incentive Grant plan or a similar state plan to target prescription drug misuse. The grant program will raise awareness about the dangers of sharing medications, fake or counterfeit pills sold online, and over prescribing. The grant will fund a total of $3 million over five years for up to six grantees.
2. MAT-PDOA: provides resources to help expand and enhance access to Medications for Opioid Use Disorder (MOUD). It will help increase the number of individuals with OUD receiving MOUD and decrease illicit opioid use and prescription opioid misuse. The grant will fund a total of $22.6 million over 5 years for up to 30 grantees.